voice search
Doxofylline Ip/bp/usp
Share

Doxofylline Ip/bp/usp

Price:

Get Latest Price

Minimum Order Quantity :

100 Kilograms

In Stock

In Stock

Product Specifications

CAS Number12171-69-6
Molecular FormulaC13H12N4O3
Molecular Weight272.26 g/mol
Purity99.5% min
AppearanceWhite powder
Packaging25kg drums
UsagePharmaceutical ingredient for treating asthma and COPD. Used in the manufacture of respiratory medications.
FeaturesBronchodilator, Asthma relief, COPD treatment, Smooth muscle relaxant
Delivery Time1 Week
Supply Ability100 Per Week
GSTIN0%

Company Details

Hema Pharmaceuticals Pvt Ltd is API and intermediate manufacturing company based at Ankleshwar, Gujarat- India. Company in manufacturing of API since 1988 and certified by WHO GMP , Certification for Env & Safety ISO 14001 : 2015 and Quality ISO 9001 : 2015.

Business Type

Exporter, Importer, Manufacturer, Supplier

Employee Count

120

Establishment

1988

Working Days

Monday To Saturday

GST NO

24AAACH4736M1ZH

Certification

Env & Safety ISO 14001:2015

Related Products

Explore Related Categories

More Product From This seller

Industry Leader

Seller Details

GST

GST - 24AAACH4736M1ZH

2 RatingRating
Super Bonanza

Ankleshwar, Gujarat

Mr Jignesh Chodvadiya

Address

Plot No.: 6201/A &B, Opp. EWAC Alloys, GIDC Estate, Ankleshwar, Gujarat, 393002, India

Report incorrect details

Compare With Similar Products

Buyer Feedback

2

3

4

Minimum Order Quantity

100 Kilograms/Kilograms

10 Kilograms/Kilograms

Delivery Time

1 Week

7 Days

Supply Ability

100 Per Week

10 Per Day

CAS No

69975-86-6

69975-86-6

Purity(%)

99

99.0% min

Physical Form

Color

Taste

Smell

Grade

HS Code

29420090

29397900

Usage

This medicine highly used for asthma and other difficult disease. It is use to treatment of symptoms related with chronic asthma and other difficult disease of the lungs. It is essentially used as a maintenance therapy. This medicine also used for COPD and bronchospasm. It has shown similar efficacy to theophylline in animal and human studies but with importantly fever side effects. The US FDA granted an orphan drug designation to Doxofylline for the treatment of bronchiectasis. In difference with other xanthine derivatives. Doxofylline does not importantly bind to adenosine alpha-1 or alpha-2 receptors and lacks stimulating effects. It does not affects calcium influx and does not affect calcium influx and also not antagonize the actions of calcium channel blockers which could explain reduced cardiac side reactions as related the drug.

Used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Molecular Weight

266.25 Grams (g)

282.26 g/mol

Molecular Formula

C11H14N4O4

C11H14N4O4

Storage

People Also Viewed